ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.62
0.96%
US Tech 100
18,064.80
0.02%
S&P 500
5,277.51
0.80%
US Dollar vs CAD
1.36535
0.00%
Bitcoin
67,560.75
0.12%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. PTC Therapeutics Inc (PTCT)

  7. PTC Therapeutics Inc (PTCT) News

PTCT

PTC Therapeutics (PTCT)

PTC Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PTCT
DateTimeSourceHeadlineSymbolCompany
05/29/20247:00AMPR Newswire (US)PTC Therapeutics to Participate at Upcoming Investor ConferenceNASDAQ:PTCTPTC Therapeutics Inc
05/28/20247:30AMPR Newswire (US)PTC Therapeutics Announces Validation of Sepiapterin European MAANASDAQ:PTCTPTC Therapeutics Inc
05/24/20244:20PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PTCTPTC Therapeutics Inc
05/22/20249:12AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PTCTPTC Therapeutics Inc
05/20/202411:20AMPR Newswire (US)PTC Therapeutics Announces European Commission Returns Translarna™ Opinion to CHMP For Re-evaluationNASDAQ:PTCTPTC Therapeutics Inc
05/20/20246:20AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PTCTPTC Therapeutics Inc
05/20/20246:00AMPR Newswire (US)PTC Therapeutics Announces European Commission Returns Translarna™ Opinion to CHMP For Re-evaluationNASDAQ:PTCTPTC Therapeutics Inc
05/14/20246:30AMPR Newswire (US)PTC Therapeutics Announces FDA Acceptance and Priority Review of the BLA for Upstaza™NASDAQ:PTCTPTC Therapeutics Inc
05/10/20244:20PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PTCTPTC Therapeutics Inc
05/08/20244:20PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PTCTPTC Therapeutics Inc
05/07/20242:30PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PTCTPTC Therapeutics Inc
05/02/20247:00AMPR Newswire (US)PTC Therapeutics to Participate at Upcoming Investor ConferencesNASDAQ:PTCTPTC Therapeutics Inc
04/25/20243:05PMPR Newswire (US)PTC Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial ResultsNASDAQ:PTCTPTC Therapeutics Inc
04/23/20243:30PMPR Newswire (US)PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:PTCTPTC Therapeutics Inc
04/11/20247:00AMPR Newswire (US)PTC Therapeutics to Host Conference Call to Discuss First Quarter 2024 Financial ResultsNASDAQ:PTCTPTC Therapeutics Inc
03/28/20247:30AMPR Newswire (US)PTC Announces Submission of Sepiapterin MAA for Treatment of PKU to EMANASDAQ:PTCTPTC Therapeutics Inc
03/19/20246:30AMPR Newswire (US)PTC Therapeutics Provides Key Regulatory UpdatesNASDAQ:PTCTPTC Therapeutics Inc
02/29/20243:05PMPR Newswire (US)PTC Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:PTCTPTC Therapeutics Inc
02/27/20244:20PMPR Newswire (US)PTC Therapeutics to Participate at Upcoming Investor ConferencesNASDAQ:PTCTPTC Therapeutics Inc
02/22/20243:30PMPR Newswire (US)PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:PTCTPTC Therapeutics Inc
02/16/20244:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PTCTPTC Therapeutics Inc
02/16/20244:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PTCTPTC Therapeutics Inc
02/16/20244:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PTCTPTC Therapeutics Inc
02/16/20243:25PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PTCTPTC Therapeutics Inc
02/16/20243:20PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PTCTPTC Therapeutics Inc
02/16/20243:20PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PTCTPTC Therapeutics Inc
02/16/20243:16PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PTCTPTC Therapeutics Inc
02/16/20243:11PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PTCTPTC Therapeutics Inc
02/16/20243:10PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PTCTPTC Therapeutics Inc
02/16/20243:10PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PTCTPTC Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:PTCT

Your Recent History

USOTC
HMBL
HUMBL (PK)
AMEX
FOXO
FOXO Technologies
USOTC
RSPI
RespireRx Pharmaceuticals (PK)
USOTC
CYDY
CytoDyn (QB)
USOTC
TPTW
TPT Global Tech (PK)
USOTC
DRNK
NoHo (PK)
USOTC
CATV
4Cable TV (PK)
USOTC
GNCP
GNCC Capital (CE)
NASDAQ
COOP
Mr Cooper
USOTC
IFUS
Impact Fusion (PK)
NASDAQ
NB
NioCorp Developments
USOTC
CEOS
CeCors (PK)
USOTC
RNVA
Rennova Health (PK)
USOTC
KEGS
1812 Brewing (PK)
USOTC
FSRN
Fisker (PK)
NASDAQ
AMRN
Amarin
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved